Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Top Cited Papers
- 1 September 2010
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 10 (9), 621-629
- https://doi.org/10.1016/s1473-3099(10)70139-0
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisPLOS ONE, 2009
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli: Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in IranChest, 2009
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisThe Lancet Infectious Diseases, 2009
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosisScience, 2009
- Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Multidrug- and Extensively Drug-Resistant Tuberculosis, GermanyEmerging Infectious Diseases, 2008
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2008
- Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary TuberculosisAntimicrobial Agents and Chemotherapy, 2008
- Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosisPLoS Pathogens, 2006
- Multiplex PCR Amplimer Conformation Analysis for Rapid Detection of gyrA Mutations in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2004